MYRIAD GENETICS INC Quarterly Costs and Expenses in USD from Q1 2010 to Q2 2024

Taxonomy & unit: us-gaap: USD
Description: Total costs of sales and operating expenses for the period.
Summary: Myriad Genetics Inc quarterly/annual Costs and Expenses history and growth rate from Q1 2010 to Q2 2024.
Myriad Genetics Inc Costs and Expenses for the quarter ending June 30, 2024 was $248M, a 16.6% decline year-over-year.
Myriad Genetics Inc Costs and Expenses for the twelve months ending June 30, 2024 was $958M, a 0.41% decline year-over-year.
Myriad Genetics Inc annual Costs and Expenses for 2023 was $1.01B, a 23.4% increase from 2022.
Myriad Genetics Inc annual Costs and Expenses for 2022 was $819M, a 7.05% decline from 2021.
Myriad Genetics Inc annual Costs and Expenses for 2021 was $881M, a 4.05% increase from 2020.

Costs and Expenses, Trailing 12 Months (USD)

Costs and Expenses, Quarterly (USD)

Costs and Expenses, YoY Quarterly Growth (%)

Period	TTM Value	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed
Q2 2024	$958M	$248M	-$49.2M	-16.6%	Apr 1, 2024	Jun 30, 2024	10-Q	2024-08-07
Q1 2024	$1.01B	$230M	-$3.3M	-1.41%	Jan 1, 2024	Mar 31, 2024	10-Q	2024-05-08
Q4 2023	$1.01B	$228M	-$2M	-0.87%	Oct 1, 2023	Dec 31, 2023	10-K	2024-02-28
Q3 2023	$1.01B	$252M	+$50.6M	+25.1%	Jul 1, 2023	Sep 30, 2023	10-Q	2023-11-07
Q2 2023	$962M	$297M	+$100M	+50.8%	Apr 1, 2023	Jun 30, 2023	10-Q	2024-08-07
Q1 2023	$862M	$233M	+$42.9M	+22.5%	Jan 1, 2023	Mar 31, 2023	10-Q	2024-05-08
Q4 2022	$819M	$230M	+$26.1M	+12.8%	Oct 1, 2022	Dec 31, 2022	10-K	2024-02-28
Q3 2022	$793M	$201M	-$45.8M	-18.5%	Jul 1, 2022	Sep 30, 2022	10-Q	2023-11-07
Q2 2022	$839M	$197M	-$13.1M	-6.23%	Apr 1, 2022	Jun 30, 2022	10-Q	2023-08-04
Q1 2022	$852M	$191M	-$29.3M	-13.3%	Jan 1, 2022	Mar 31, 2022	10-Q	2023-05-04
Q4 2021	$881M	$204M	+$1.1M	+0.54%	Oct 1, 2021	Dec 31, 2021	10-K	2024-02-28
Q3 2021	$880M	$247M	+$62.4M	+33.8%	Jul 1, 2021	Sep 30, 2021	10-Q	2022-11-02
Q2 2021	$818M	$210M	+$48.7M	+30.2%	Apr 1, 2021	Jun 30, 2021	10-Q	2022-08-05
Q1 2021	$769M	$220M	-$77.9M	-26.2%	Jan 1, 2021	Mar 31, 2021	10-Q	2022-05-06
Q4 2020	$847M	$203M	-$1.1M	-0.54%	Oct 1, 2020	Dec 31, 2020	10-KT	2021-03-16
Q3 2020	$848M	$185M	-$22.4M	-10.8%	Jul 1, 2020	Sep 30, 2020	10-Q	2021-11-04
Q2 2020	$870M	$162M	-$59.5M	-26.9%	Apr 1, 2020	Jun 30, 2020	10-Q	2021-08-04
Q1 2020	$930M	$298M	+$87M	+41.3%	Jan 1, 2020	Mar 31, 2020	10-Q	2021-05-05
Q4 2019	$843M	$204M	-$6.8M	-3.23%	Oct 1, 2019	Dec 31, 2019	10-KT	2021-03-16
Q3 2019	$850M	$207M	+$6.1M	+3.03%	Jul 1, 2019	Sep 30, 2019	10-KT	2021-03-16
Q2 2019	$844M	$221M	+$44.9M	+25.5%	Apr 1, 2019	Jun 30, 2019	10-KT	2021-03-16
Q1 2019	$799M	$211M	+$41.4M	+24.5%	Jan 1, 2019	Mar 31, 2019	10-KT	2021-03-16
Q4 2018	$757M	$211M	+$29.1M	+16%	Oct 1, 2018	Dec 31, 2018	10-KT	2021-03-16
Q3 2018	$728M	$201M	+$106M	+112%	Jul 1, 2018	Sep 30, 2018	10-KT	2021-03-16
Q2 2018	$622M	$176M	-$4.6M	-2.55%	Apr 1, 2018	Jun 30, 2018	10-K	2019-08-13
Q1 2018	$626M	$169M	-$19.9M	-10.5%	Jan 1, 2018	Mar 31, 2018	10-K	2019-08-13
Q4 2017	$646M	$182M	+$2.1M	+1.17%	Oct 1, 2017	Dec 31, 2017	10-K	2019-08-13
Q3 2017	$644M	$94.8M	-$77M	-44.8%	Jul 1, 2017	Sep 30, 2017	10-K	2019-08-13
Q2 2017	$721M	$181M	+$29.8M	+19.7%	Apr 1, 2017	Jun 30, 2017	10-K	2018-08-24
Q1 2017	$691M	$189M	+$41.3M	+27.9%	Jan 1, 2017	Mar 31, 2017	10-K	2018-08-24
Q4 2016	$650M	$180M	+$31.4M	+21.2%	Oct 1, 2016	Dec 31, 2016	10-K	2018-08-24
Q3 2016	$619M	$172M	+$31.6M	+22.5%	Jul 1, 2016	Sep 30, 2016	10-K	2018-08-24
Q2 2016	$587M	$151M	-$2.7M	-1.76%	Apr 1, 2016	Jun 30, 2016	10-K	2018-08-24
Q1 2016	$590M	$148M	+$3.6M	+2.5%	Jan 1, 2016	Mar 31, 2016	10-Q	2017-05-03
Q4 2015	$586M	$148M	$0	0%	Oct 1, 2015	Dec 31, 2015	10-Q	2017-02-08
Q3 2015	$586M	$140M	-$2.7M	-1.89%	Jul 1, 2015	Sep 30, 2015	10-Q	2016-11-02
Q2 2015	$589M	$154M	+$18.1M	+13.3%	Apr 1, 2015	Jun 30, 2015	10-K	2018-08-24
Q1 2015	$571M	$144M	+$16.7M	+13.1%	Jan 1, 2015	Mar 31, 2015	10-Q	2016-05-04
Q4 2014	$554M	$148M	+$27M	+22.3%	Oct 1, 2014	Dec 31, 2014	10-Q	2016-02-03
Q3 2014	$527M	$143M	+$23.3M	+19.5%	Jul 1, 2014	Sep 30, 2014	10-Q	2015-11-04
Q2 2014	$504M	$136M	+$27.3M	+25.2%	Apr 1, 2014	Jun 30, 2014	10-K	2016-08-10
Q1 2014	$476M	$128M	+$29.1M	+29.5%	Jan 1, 2014	Mar 31, 2014	10-Q	2015-05-06
Q4 2013	$447M	$121M	+$27.5M	+29.4%	Oct 1, 2013	Dec 31, 2013	10-Q	2015-02-04
Q3 2013	$420M	$120M	+$34.7M	+40.9%	Jul 1, 2013	Sep 30, 2013	10-Q	2014-11-05
Q2 2013	$385M	$108M	+$22.6M	+26.3%	Apr 1, 2013	Jun 30, 2013	10-K	2015-08-12
Q1 2013	$363M	$98.6M	+$14.9M	+17.8%	Jan 1, 2013	Mar 31, 2013	10-Q	2014-05-07
Q4 2012	$348M	$93.6M	+$16.2M	+21%	Oct 1, 2012	Dec 31, 2012	10-Q	2014-02-05
Q3 2012	$332M	$84.9M	+$15.9M	+23%	Jul 1, 2012	Sep 30, 2012	10-Q	2013-11-12
Q2 2012	$316M	$85.7M	+$20M	+30.5%	Apr 1, 2012	Jun 30, 2012	10-K	2014-08-13
Q1 2012	$296M	$83.7M	+$23.1M	+38.2%	Jan 1, 2012	Mar 31, 2012	10-Q	2013-05-08
Q4 2011	$273M	$77.3M	+$15.5M	+25%	Oct 1, 2011	Dec 31, 2011	10-Q	2013-02-06
Q3 2011	$257M	$69M	+$12.7M	+22.6%	Jul 1, 2011	Sep 30, 2011	10-Q	2012-11-09
Q2 2011	$244M	$65.6M			Apr 1, 2011	Jun 30, 2011	10-K	2013-08-14
Q1 2011		$60.6M	+$2.95M	+5.11%	Jan 1, 2011	Mar 31, 2011	10-Q	2012-05-02
Q4 2010		$61.9M			Oct 1, 2010	Dec 31, 2010	10-Q	2012-02-01
Q3 2010		$56.3M			Jul 1, 2010	Sep 30, 2010	10-Q	2011-11-02
Q1 2010		$57.6M			Jan 1, 2010	Mar 31, 2010	10-Q	2011-05-04

* An asterisk sign (*) next to the value indicates that the value is likely invalid.